$295.03+0.20%Close 13 Nov 2026 · Market value $525.9B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
AbbVie Inc. is valued at $525.9B on its latest close. Its price is 51.1 times its earnings.
| Market value | $525.9B |
|---|
| Enterprise value | $591.7B |
|---|
| Price / earnings | 51.07 |
|---|
| Price / sales | 7.97 |
|---|
| EV / EBITDA | 20.44 |
|---|
| EV / sales | 8.96 |
|---|
| Price / free cash flow | 27.87 |
|---|
| Price / free cash flow, own 5-year average | 16.12 |
|---|
| EV / EBIT | 28.07 |
|---|
| EV / free cash flow | 31.58 |
|---|
| Free cash flow yield | 3.6% |
|---|
| Dividend yield | 2.3% |
|---|
Share price
| Latest close | $295.03 |
|---|
| Day's change | +0.2% |
|---|
| 52-week high | $302.93 |
|---|
| 52-week low | $190.75 |
|---|
| From 52-week high | −2.6% |
|---|
| Return · 1 month | +3.4% |
|---|
| Return · 3 months | +12.7% |
|---|
| Return · year to date | +29.1% |
|---|
| Return · 1 year | +26.5% |
|---|
| Beta · 1 year against the S&P 500 | −0.02 |
|---|
| 50-day average | $275.51 |
|---|
| 200-day average | $240.79 |
|---|
| RSI 14 | 62.6 |
|---|
| Average volume · 20 sessions | 5.2M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 70.2% |
|---|
| Operating margin | 24.6% |
|---|
| Net margin | 6.9% |
|---|
| Free cash flow margin | 29.1% |
|---|
| Return on assets | 7.2% |
|---|
| Return on invested capital | 9.5% |
|---|
| Return on invested capital, 5-year average | 10.3% |
|---|
| Return on capital employed | 16.1% |
|---|
| Stock-based compensation / revenue | 1.6% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $5.23B |
|---|
| Total debt | $68.38B |
|---|
| Net debt | $63.12B |
|---|
| Current ratio | 0.67 |
|---|
| Quick ratio | 0.56 |
|---|
| Net debt / EBITDA | 2.72 |
|---|
| Interest coverage | 5.21 |
|---|
Growth
| Revenue, latest quarter on a year | +10.3% |
|---|
| Revenue, twelve months on a year | +10.7% |
|---|
| EPS, latest quarter on a year | +2270% |
|---|
| EPS, twelve months on a year | +338% |
|---|
| Revenue, 5-year compound | +6.0% |
|---|
| Revenue, 10-year compound | +10.3% |
|---|
| Net income, 5-year compound | −1.8% |
|---|
| Free cash flow, 5-year compound | +1.2% |
|---|
| EPS, 5-year compound | −2.8% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 1.8B |
|---|
| Shares outstanding, 5-year compound | +1.2% |
|---|
| Net share repurchases | $808.0M |
|---|
| Dividends per share | $6.65 |
|---|
| Dividend payout | 276% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $2.36B |
|---|
| Effective tax rate | 35.8% |
|---|
ABBV in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.